Aleksander Lenert, MD, FRCPC

Articles: Lenert A, Niewold TB, Lenert P. Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Des Devel Ther. 2017 Mar 13;11:747-757. eCollection 2017. Review. PubMed PMID: 28331294. Lenert A, Fardo DW. Detecting Novel Micro RNAs in Rheumatoid Arthritis with Gene-based Association Testing. Clinical and Experimental Rheumatology. Clin Exp Rheumatol. 2017 Jan 27. PubMed PMID: 28134081. Lenert A, Lenert P. Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice. Clin Rheumatol. 2016 Nov 28. PubMed PMID: 27896522. Lenert A, Yao Q. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature. Semin Arthritis Rheum. 2016 Jun;45(6):711-6. Lenert A, Lenert P. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents. Drug Des Devel Ther. 2015 Jan 7;9:333-47. Abstracts: Lenert A, Fardo DW. Novel Non-Coding RNAs Associated with Rheumatoid Arthritis in Asians by Gene-Based Testing. Arthritis Rheumatol. 2017; 69 (suppl 10). Lenert A, Kim S. Patient Education Materials in Rheumatology: Only Adequate at Best. Arthritis Rheumatol. 2017; 69 (suppl 10). Ramey W, Lohr KM, Zeltner M, Herrell Postonl H, Johannemann A, Schadler AD, Lenert A. Biological and Targeted SYnthetic Dmards' Prior Authorization Time is Significantly Reduced with Pharmacy Presence in the Rheumatology Clinic. Arthritis Rheumatol. 2017; 69 (suppl 10). Lenert A, Fardo D. Detecting Novel Candidate Risk Genes in Rheumatoid Arthritis with Gene-Based Association Testing. Arthritis Rheumatol. 2016; 68 (suppl 10).